Larger studies further associate chemotherapy-related increases in IL-6, TNF-α, and soluble TNF receptors with impaired physical function and fatigue (e.g., [24]), while smaller cohorts link IL-6 and MCP-1 elevations with cognitive decline (e.g., [25,26,27]). This evidence concerns the gene IL6 and Mental deterioration.